Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children
Alexandra Chera, Antoanela Tanca
Discoveries (2022) Vol. 10, Iss. 2, pp. e151-e151
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Deuremidevir and Simnotrelvir–Ritonavir for the Treatment of COVID-19
Ke‐Wei Zhu
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 9, pp. 1306-1309
Open Access | Times Cited: 24
Harvesting phosphorus-containing moieties for their antibacterial effects
Manuela Voráčová, Matej Zore, Jari Yli‐Kauhaluoma, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117512-117512
Open Access | Times Cited: 20
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115380-115380
Open Access | Times Cited: 16
Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies
Abdou K. Allayeh, Aliaa H. El-boghdady, Mohamed A. Said, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 198-198
Open Access | Times Cited: 5
New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 5
Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections
Ankita Saha, Anirban Ganguly, Anoop Kumar, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics
Zirui Lü, Xiandong Dai, Jianjie Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116442-116442
Closed Access | Times Cited: 4
Solid-state ion-selective electrodes for the first potentiometric determination of the anti-COVID 19 drug Remdesivir in human plasma; A comparative study
Noha F. El Azab, Neven Ahmed
Microchemical Journal (2023) Vol. 190, pp. 108658-108658
Open Access | Times Cited: 8
Remdesivir Efficacy and Tolerability in Children with COVID-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
Gheorghiță Jugulete, Monica Luminos, Carmen Pavelescu, et al.
Children (2023) Vol. 10, Iss. 5, pp. 810-810
Open Access | Times Cited: 8
3C-like proteases in SARS-CoV-2
Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, et al.
Bioscience Reports (2024)
Open Access | Times Cited: 2
Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening
Mohamed G. Abouelenein, Aliaa H. El-boghdady, Hadeer M. Ali, et al.
Polycyclic aromatic compounds (2024), pp. 1-18
Closed Access | Times Cited: 2
An Updated Systematic Review on Remdesivir’s Safety and Efficacy in Patients Afflicted With COVID-19
Mohamed Yasir, Chetan Reddy Lankala, Pravin Panditrao Kalyankar, et al.
Cureus (2023)
Open Access | Times Cited: 6
Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells
Lai‐Keng Loi, Cheng‐Chieh Yang, Yu‐Cheng Lin, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22614-e22614
Open Access | Times Cited: 6
In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1
Advances and Challenges in Antiviral Development for Respiratory Viruses
Luis Adrián De Jesús‐González, Moisés León‐Juárez, Flor Itzel Lira-Hernández, et al.
Pathogens (2024) Vol. 14, Iss. 1, pp. 20-20
Open Access | Times Cited: 1
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine
Irina Vlasova-St. Louis, Daniel Fang, Yara Amer, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 45-45
Open Access | Times Cited: 3
In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2
Calvin R. Wei, Godwin C. Lang’at
(2023)
Open Access | Times Cited: 2
Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection – a single-center, retrospective, cohort study
Karolina Kautsch, Joanna Wiśniowska, Joanna Friedman-Gruszczyńska, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 2, pp. 591-598
Open Access | Times Cited: 2
Justification of Intensive care management of children with severe COVID19 (а case study)
Р.В. Ткачук, О.К. Колоскова, М.N. Garas, et al.
Ukrainian Scientific Medical Youth Journal (2024) Vol. 144, Iss. 1, pp. 208-215
Open Access
Nirmatrelvir-ritonavir efficacy and safety in high-risk COVID-19 patients: a review of recent retrospective cohort studies – nephrology point of view
Alireza Amin, Shiva Maleki, Mohammad Reza Moonesan
Journal of Renal Injury Prevention (2024)
Open Access
Mechanistic understanding of dexamethasone-mediated protectionagainst remdesivir-induced hepatotoxicity
Kaiyan Liu, Zhihui Li, Linhao Li, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 71-82
Open Access
Home Remedy Practices Among Stay-at-Home COVID-19 Patients in Bangladesh
Md. Abu Bakar Siddique Jami, Ritu Islam, Rezwana Sultana, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 142-151
Open Access
Evolution of drug resistance against antiviral agents that target cellular factors
Naveen Kumar, Shalini Sharma, Ram Kumar, et al.
Virology (2024) Vol. 600, pp. 110239-110239
Closed Access
The first five years of SARS-CoV-2: inpatient treatment updates and future directions
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 14, pp. 1873-1878
Closed Access
The Use of Remdesivir in Patients with COVID-19
Zeinab Mohseni Afshar, Dariush Hosseinzadeh, Rezvan Hosseinzadeh, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 7
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top